Leukemia

Oral inhibitor shows clinical activity in poor-prognosis AML

An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators ...

Dec 08, 2014
popularity not rated yet | comments 0

Why CLL there are often relapses after treatment

Chronic lymphocytic leukemia (CLL) is among the most frequent leukemias affecting adults in Western countries. It usually occurs in older patients, does not cause any symptoms for a long time and is often only discovered ...

Dec 05, 2014
popularity 5 / 5 (2) | comments 0

Blincyto approved for rare leukemia

(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.

Dec 03, 2014
popularity not rated yet | comments 0

How red wine prevents cancer

Alcohol use is a major risk factor for head and neck cancer. But an article published in the November issue of the journal Advances in Experimental Medicine and Biology shows that the chemical resveratrol found ...

Dec 03, 2014
popularity 4.8 / 5 (4) | comments 0

New substance overcomes treatment-restistance in leukemia

Haematologists from Goethe University Frankfurt, working with a Russian pharmaceutical company, have developed a new active substance that effectively combats the most aggressive forms of Philadelphia chromosome-positive ...

Dec 01, 2014
popularity 5 / 5 (2) | comments 0

Gene test aids cancer profile

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

Nov 27, 2014
popularity 5 / 5 (1) | comments 0

Latest Spotlight News

The hunt for botanicals

Herbal medicine can be a double-edged sword and should be more rigorously investigated for both its beneficial and harmful effects, say researchers writing in a special supplement of Science.

Putting the brakes on cancer

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...